Virginia Retirement Systems’s Fate Therapeutics FATE Stock Holding History

Virginia Retirement Systems’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$89.7K	Buy	42,300 +8,700	+26%	+$28.8K	﹤0.01%	924
2023 Q2	$160K	Buy	33,600 +15,600	+87%	+$86.1K	﹤0.01%	936
2023 Q1	$103K	Buy	18,000 +5,600	+45%	+$33.8K	﹤0.01%	1004
2022 Q4	$125K	Buy	+12,400	New	+$233K	﹤0.01%	1087
2021 Q4	–	Sell	-5,500	Closed	-$326K	–	1121
2021 Q3	$326K	Sell	5,500 -800	-13%	-$62.8K	﹤0.01%	866
2021 Q2	$547K	Buy	6,300 +3,400	+117%	+$274K	0.01%	809
2021 Q1	$239K	Buy	+2,900	New	+$278K	﹤0.01%	1044

Other funds holding FATE

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Virginia Retirement Systems's FATE Position: Q3 2023 in Review

Virginia Retirement Systems increased its Fate Therapeutics (FATE) stake by 26% in Q3 2023, buying an estimated $28.8K and bringing the position to 42,300 shares worth $89.7K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Virginia Retirement Systems first reported a position in FATE in Q1 2021 and has held it in 7 quarters since. The position peaked at $547K in Q2 2021. 170 funds tracked by Wall St. Rank hold FATE as of Q3 2023.

Virginia Retirement Systems held 42,300 shares of Fate Therapeutics worth $89.7K as of Q3 2023.
Virginia Retirement Systems bought 8,700 Fate Therapeutics shares in Q3 2023, an estimated $28.8K.
Fate Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #924 holding.
Virginia Retirement Systems first reported a position in Fate Therapeutics in Q1 2021 and has held it in 7 quarters since.
Virginia Retirement Systems's Fate Therapeutics position peaked at $547K in Q2 2021.
170 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.